Molecular Partners (MOLN)

• Market cap: $142M
• 1 day: -1.03%
• 5 days: -9.43%
• 1 month: -17.95%
• 3 months: -21.15%
• 6 months: -19.83%
• Year to date: -21.15%
• 1 year: -1.54%
• 5 years: -80.46%
• 10 years: -80.46%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

306% more capital invested

Capital invested by funds: $4.2M [Q3] → $17M (+$12.8M) [Q4]

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

6.56% more ownership

Funds ownership: 2.31% [Q3] → 8.88% (+6.56%) [Q4]

0% more funds holding

Funds holding: 5 [Q3] → 5 (+0) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $12 213% upside
• Avg. target: $12 213% upside
• High target: $12 213% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

LifeSci Capital

213% upside $12

Outperform Initiated

11 Mar 2025